v3 Template
A

Azalea Therapeutics

Biotechnology / Healthcare ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$82.0M
Funding Rounds
1
Last Funding
2025-11-04

About Azalea Therapeutics

Azalea Therapeutics is focused on redefining precision genomic medicines by delivering therapies with unparalleled accuracy directly inside the body. Their mission is to create life-changing treatments, initially targeting cancer immunotherapies, using advanced genome editing tools to engineer T cells in vivo, making cell therapy faster, more accessible, and scalable for a wide range of cancers.

Products & Services

In Vivo Cancer Immunotherapies:Azalea is developing therapies that turn a person's own T cells into powerful cancer treatments directly inside the body using precision genome editing tools and Envelope Delivery Vehicles (EDVs) to target and modify T cells safely and effectively.
Envelope Delivery Vehicles (EDVs):Highly selective delivery systems designed to locate T cells within the patient and deliver genome engineering cargo for precise anti-cancer modifications.

Specialties

Precision Genome Engineering In Vivo Cancer Immunotherapies Cell Therapy CRISPR-Cas Genome Editing Envelope Delivery Vehicles (EDVs)

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed and Series A
T: -
FT: Seed and Series A
A: 82000000
MR: -
FA: $82 million
FAN: 82000000
D: 2025-11-04
FD: 2025-11-04
5 investors
Seed and Series A Latest
2025-11-04
$82.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jenny Hamilton

Co-founder, President and Chief Executive Officer

LinkedIn (Pro only)
P

Paul Westberg

Chief Business Officer

LinkedIn (Pro only)
C

Connor Tsuchida

Scientific Cofounder

LinkedIn (Pro only)
A

Abdullah Syed

Scientific co-founder

J

Jennifer Doudna

Nobel Laureate in Chemistry; Professor; Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences

J

Justin Eyquem

Principal Investigator

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Azalea Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~260 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro